> SKILARENCE should be used cautiously in combination with other  systemic antipsoriatic therapy (e.g. METHOTREXATE, retinoi ds, psoralens , ciclo sporin, i mmunosuppressants or  cytostati cs) (see sect ion 4.4 ). During treatment , simu ltaneous use of other fumaric acid derivatives (topical or systemic) should be avoided. 
> Concurrent therapy with nephrotoxic substances  (e.g. METHOTREXATE, ciclosp orin, aminoglycosides, DIURETICS , non-steroi dal anti -inflam matory drugs ( NSAIDs ) or LITHIUM) may increase t he potential for renal adverse reactions (e.g. proteinuria) in patients taking SKILARENCE .
